These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4622667)

  • 21. A comparison of the effects of some monoamine oxidase (MAO) inhibitors with 5-hydroxytryptophan (5-HTP) and dihydroxyphenylalanine (DOPA) on spinal synaptic activity.
    Anderson EG; Baker R; Banna N
    Proc West Pharmacol Soc; 1966; 9():40-1. PubMed ID: 5958499
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacological studies on 10-chloro-11b-(2-chlorophenyl)-2,3,5,6,7,11b-hexahydrobenzo-(6,7)-1,4-diazepino(5,4-b)-oxazol-6-one (CS-370), a new psychosedative agent.
    Kamioka T; Takagi H; Kobayashi S; Suzuki Y
    Arzneimittelforschung; 1972 May; 22(5):884-91. PubMed ID: 4626013
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pharmacological studies of oxazolazepam, a new psychotropic agent. I. Actions on the central nervous system, especially on the behavioral aspect].
    Takagi H; Kamioka T; Kobayashi S; Suzuki Y; Tachikawa R
    Nihon Yakurigaku Zasshi; 1970; 66(1):107-33. PubMed ID: 4987943
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacologic profile of fezolamine fumarate: a nontricyclic antidepressant in animal models.
    Baizman ER; Ezrin AM; Ferrari RA; Luttinger D
    J Pharmacol Exp Ther; 1987 Oct; 243(1):40-54. PubMed ID: 3668867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drugs and sleep.
    Oswald I
    Pharmacol Rev; 1968 Dec; 20(4):273-303. PubMed ID: 4305226
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacological studies on 2-methyl-3(2'-methyl-4'-chlorophenyl)-5-chloro-4[H)-quinazolinone (SL-164).
    Saito C; Sakai S; Yukawa Y; Yamamoto H; Takagi H
    Arzneimittelforschung; 1969 Dec; 19(12):1945-9. PubMed ID: 4985336
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the pharmacology of the new psychoactive drug 7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine (Ro5-4556)].
    Randall LO; Schallek W; Scheckel C; Banziger R; Moe RA
    Arzneimittelforschung; 1968 Dec; 18(12):1542-5. PubMed ID: 4975663
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacology of trazodone.
    Silverstrini B; Lisciani R
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):749-54. PubMed ID: 4201971
    [No Abstract]   [Full Text] [Related]  

  • 29. The influence of some MAO inhibitors and neuroleptics on enzymes concerned in GABA metabolism.
    Simánĕ Z; Kraus P
    Act Nerv Super (Praha); 1968 Oct; 10(3):331. PubMed ID: 4387433
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemistry and pharmacology of a new potential antidepressant. (N-methyl-N-[4-chlorobenzyl-methyl-3-(10,11-dihydro-5H-dibenz(b,f) azepin-5-yl)]-propylamine hydrochloride). (Leo 640, lopraminehydrochloride).
    Eriksoo E; Rohte O
    Arzneimittelforschung; 1970 Oct; 20(10):1561-9. PubMed ID: 4394726
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis and antidepressant activity of 5-phenyl-2-(2-propynylamino)-2-oxazolin-4-one and derivatives.
    Lee CM; Horrom BW; Michaels RJ; Rasmussen RM; Plotnikoff NP
    J Med Chem; 1972 Dec; 15(12):1252-5. PubMed ID: 4635969
    [No Abstract]   [Full Text] [Related]  

  • 32. [Neuroleptics, monoamine oxidase inhibitors and dopamine beta hydroxylase inhibitors: their actions and interactions].
    Vetulani J
    Postepy Hig Med Dosw; 1973; 27(6):725-80. PubMed ID: 4589208
    [No Abstract]   [Full Text] [Related]  

  • 33. Proceedings: Neurotropic effects of thyrotropin releasing hormone (TRH).
    Kruse H
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R51. PubMed ID: 4276591
    [No Abstract]   [Full Text] [Related]  

  • 34. OI 77, a new tricyclic antidepressant.
    van Riezen H; van der Burg WJ; Berendsen H; Jaspar ML
    Arzneimittelforschung; 1973 Sep; 23(9):1295-302. PubMed ID: 4801224
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential effects of monoamine oxidase inhibitors.
    Maickel RP; Rompalo AM; Cox RH
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):727-30. PubMed ID: 4420181
    [No Abstract]   [Full Text] [Related]  

  • 36. The analysis of cardiovascular action of 10-(3-dimethylaminopropyl)-7-chlorobenzo-(b)-(1,8)-naphthyridone-5 monohydrochloride (IF-C-45) with antidepressant properties.
    Filczewski M; Oledka K; Ernest K; Paszek T
    Pol J Pharmacol Pharm; 1975; 27(2):121-37. PubMed ID: 1153349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral effects and general pharmacology of 4-(5-chloro-benzofuranyl-2)-1-methylpiperidine HC1, an antidepressant inhibiting both monoamine oxidase A and 5-hydroxytryptamine uptake.
    Ortmann R; Radeke E; Buech O; Sigg K; Rogg H; Glatt A; Truog A; Jaekel J; Everitt BJ; Delini-Stula A
    Arzneimittelforschung; 1986 Dec; 36(12):1727-32. PubMed ID: 3566833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sintamil -a new dibenzoxazepine antidepressant.
    Nagarajan K; David J; Kaul CL; Maller RK; Rao RR; Grewal RS
    Indian J Physiol Pharmacol; 1975; 19(1):39-42. PubMed ID: 808468
    [No Abstract]   [Full Text] [Related]  

  • 39. Preclinical evaluation of AHR-2244 a new psychotherapeutic agent.
    Johnson DN; Funderburk WH; Ward JW
    Arch Int Pharmacodyn Ther; 1974 Oct; 211(2):326-40. PubMed ID: 4477709
    [No Abstract]   [Full Text] [Related]  

  • 40. [Psychotropic activity under the influence of fenpentadiol].
    Ginet J; Levy JC; Rolland D
    Arzneimittelforschung; 1971 Jan; 21(1):1-8. PubMed ID: 4396676
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.